Government of Mexico
Also known as: CCINSHAE. Secretaría de Salud. México | Centro de Investigación en. Enfermedades Infecciosas, Mexico | Centro Mexicano Universitario de Ciencias y Humanidades (CMUCH), Puebla, México | Centro Nacional de Vigilancia Epidemiológica y control de enfermedades (CENAVECE), Mexico | Centro Universitario de Ciencias de la Salud, Mexico | Comprehensive Center for Mental Health Tzompantepec, Secretary of Health Tlaxcala | Coordinación de Investigación en Salud | Coordinación de Investigación en Salud, México. | Coordinación de Investigación en Salud, Mexico | Coordinación de Investigación en Salud, México | Division of Clinical Research, IInstituto Nacional de Cancerologia, Mexico | Gilberto Cruz Arteaga | Hospital Infantil de México Dr. Federico Gómez | Hospital Infantil de Mexico Federico Gomez | Hospital Regional de Alta Especialidad de la Península de Yucatán | Instituto de Diagnóstico y Referencia Epidemiológicos (InDRE), Mexico | Instituto Nacional de CancerologÃa de México | Instituto Nacional de Cancerologia de Mexico | Instituto Nacional de Cancerologia Mexico | Instituto Nacional de Cancerologia, Mexico | Instituto Nacional de Salud Pública | Instituto Nacional de Salud Publica (INSP) | Instituto Nacional de Salud Publica, Mexico | LILIA GONZALEZ CERON | Mexican National Institute of Public Health | Mexico. National Cancer Institute | Mexico: Secretaria de Salud | Ministry of Health, Mexico City | National Center of Blood Transfusion Mexico. | National Council of Science and Technology, Mexico | National Heart Institute, Mexico | National Insitute of Pediatrics, Mexico | NATIONAL INSTITUTE FOR PUBLIC HEALTH-MEXICO | National Institute of Cancer of Mexico | National Institute of Cancerologia, Mexico | National Institute of CanerologÃa | National Institute of Neurology and Neurosurgery, Mexico | National Institute of Neurology and Neurosurgery of Mexico | National Institute of Pediatrics in Mexico | National Institute of Pediatrics, Mexico | National Institute of Perinatology | National Institute of Perinatology, Mexico City | National Institute of public Health | National Institute of Public Health and Ministry of Health, Mexico | National Institute of Public Health Mexico | National Institute of Public Health, Mexico | National Institute of Rehabilitation | National Institute of Respiratory Diseases (INER) | National Institute of Respiratory Diseases, Mexico | National Institute of Respiratory Diseases - México | Secretaria de Salud, Mexico | Torre Mayo, Metepec, State of Mexico
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2000Last known activity
Mar 1, 2025
Timeline
1820s
- Jan 1, 1824
Government of Mexico— Founded
Drugs by trial phase (194 distinct, 205 trials)
Phase 4 (55 own, 0 via acquisition)
Phase 3 (59 own, 0 via acquisition)
Phase 2 (45 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (34 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Acute Kidney Injury
- Anorexia
- Anxiety Disorders
- Asthma
- Brain Neoplasms
- Breast Neoplasms
- Cachexia
- Carcinoma in Situ
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Cervical Intraepithelial Neoplasia
- Coinfection
- Communicable Diseases
- Corneal Neovascularization
- Coronary Artery Disease
- Coronary Disease
- Coronavirus Infections
- Critical Illness
- Cystic Fibrosis
- Death
- Depression
- Depressive Disorder
- Depressive Disorder, Treatment-Resistant
- Dermatitis
- Dermatitis, Atopic
- Diabetes, Gestational
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Diarrhea
- Drug Resistant Epilepsy
- Dyslipidemias
- Eczema
- Enterocolitis
- Enterocolitis, Necrotizing
- Epilepsy
- Exanthema
- Febrile Neutropenia
- Fetal Death
- Fever
- Fibrosis
- Gastritis
- Glioblastoma
- Glioma
- Glucose Intolerance
- Heart Diseases
- Helicobacter Infections
- Hepatitis C
- HIV Infections
- Hyperlipidemias
- Hyperlipoproteinemias
- Hyperplasia
- Hypertension
- Hypertension, Pulmonary
- Hyperuricemia
- Immunologic Deficiency Syndromes
- Infarction
- Infections
- Inflammation
- Influenza, Human
- Insulin Resistance
- Kidney Diseases
- Kidney Failure, Chronic
- Labor Pain
- Latent Tuberculosis
- Leukemia
- Leukemia, Lymphoid
- Lung Neoplasms
- Lupus Erythematosus, Systemic
- Major Depressive Disorder
- Malaria
- Malnutrition
- Mesothelioma
- Metabolic Diseases
- Metabolic Syndrome
- Mucositis
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Muscular Dystrophies
- Muscular Dystrophy, Duchenne
- Myocardial Infarction
- Myocardial Ischemia
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Second Primary
- Neovascularization, Pathologic
- Neutropenia
- Obesity
- Osteoarthritis
- Osteoarthritis, Knee
- Ovarian Neoplasms
- Overweight
- Papilloma
- Papillomavirus Infections
- Pneumonia
- Polycystic Ovary Syndrome
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Premature Birth
- Radiation Pneumonitis
Recent trials (50)
- NCT06847373CollaboratorN/AMar 1, 2025
- NCT06847373Lead sponsorN/AMar 1, 2025
- NCT07248761OfficialPhase 4Feb 1, 2025
- NCT07248761Lead sponsorPhase 4Feb 1, 2025
- NCT06748105Lead sponsorPhase 2Dec 1, 2024
- NCT06748105Sponsor investigatorPhase 2Dec 1, 2024
- NCT06531460Lead sponsorN/AJul 25, 2024
- NCT06531460Sponsor investigatorN/AJul 25, 2024
- NCT06254001Sponsor investigatorPhase 4Jan 15, 2024
- NCT06254001Lead sponsorPhase 4Jan 15, 2024
- NCT07275177CollaboratorN/AJan 9, 2024
- NCT06496100Lead sponsorPhase 3Jan 3, 2024
- NCT06422533Sponsor investigatorN/ANov 7, 2023
- NCT06422533Lead sponsorN/ANov 7, 2023
- NCT05852145Reponsible party - principal investigatorPhase 1/Phase 2Oct 31, 2023
Details
- Founded
- Mexico City, MX Jan 1, 1824
- Last known activity
- Mar 1, 2025